ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,332Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 97

$720K Total Retail Price of All Prescriptions

Rank: 15 out of 97

558 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 558 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

4% of this provider’s 558 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 13,418 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
LEVOTHYROXINE SODIUM 889 845 1 1
FUROSEMIDE 646 628 2 3
AMLODIPINE BESYLATE 567 567 3 6
OMEPRAZOLE 462 428 4 5
LISINOPRIL 455 433 5 4
METFORMIN HCL 440 399 6 12
POTASSIUM CHLORIDE 415 393 7 10
SIMVASTATIN 407 396 8 2
METOPROLOL SUCCINATE 318 316 9 8
LOSARTAN POTASSIUM 298 279 10 13
ATENOLOL 285 271 11 15
HYDROCHLOROTHIAZIDE 282 259 12 9
METOPROLOL TARTRATE 267 255 13 7
ATORVASTATIN CALCIUM 242 211 14 14
ALLOPURINOL 241 235 15 22
GABAPENTIN 234 220 16 18
CRESTOR 219 210 17 29
LOVASTATIN 216 200 18 62
TRAMADOL HCL 214 213 19 21
WARFARIN SODIUM 196 194 20 11
GLIPIZIDE ER 168 144 21 111
DIOVAN 146 121 22 44
ZETIA 135 128 23 51
ALENDRONATE SODIUM 124 124 24 19
SERTRALINE HCL 124 110 24 16
JANTOVEN 124 124 24 37
DONEPEZIL HCL 119 119 27 24
AMITRIPTYLINE HCL 119 109 R 27 54
FENOFIBRATE 117 97 29 113
GLYBURIDE 116 104 R 30 75
SPIRONOLACTONE 108 104 31 33
LOVAZA 104 102 32 146
RAMIPRIL 102 85 33 68
DIGOXIN 98 85 34 26
ENALAPRIL MALEATE 97 89 35 47
ZOLPIDEM TARTRATE 97 95 35 32
TRICOR 92 69 37 125
GLIPIZIDE XL 89 88 38 86
PEN NEEDLE 86 62 39 57
NAMENDA 82 82 40 38
POLYETHYLENE GLYCOL 3350 82 78 40 55
LANTUS SOLOSTAR 78 67 42 41
KLOR-CON M20 76 70 43 92
CLOPIDOGREL 74 74 44 34
BENAZEPRIL HCL 74 74 44 109
BYSTOLIC 70 70 46 99
NEXIUM 70 60 46 66
LANTUS 70 58 46 43
CARVEDILOL 69 65 49 25
TAMSULOSIN HCL 68 66 50 31
SPIRIVA 68 57 50 48
CITALOPRAM HBR 67 67 52 20
SYNTHROID 67 67 52 108
PAROXETINE HCL 62 62 54 56
QUINAPRIL HCL 61 57 55 146
JANUVIA 61 43 55 59
KLOR-CON 10 59 54 57 65
LIPITOR 57 51 58 91
ESCITALOPRAM OXALATE 56 56 59 93
CARBIDOPA-LEVODOPA 55 55 60 61
HUMALOG 55 45 60 77
PLAVIX 55 55 60 46
HYDROCODONE-ACETAMINOPHEN 54 53 S3 63 17
NOVOLOG FLEXPEN 54 39 63 74
COMBIVENT 53 50 65 226
FENTANYL 52 48 S2 66 50
DOXAZOSIN MESYLATE 52 43 66 45
PROPRANOLOL HCL 51 51 68 83
VYTORIN 50 45 69 127
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 15, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.